Solid Tumors in Pediatric Patients

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-03-01
Clinical Trial Update: A Study of Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-056) [Phase 1]
Phase 1 trial update for ridaforolimus (MK-8669) in pediatric participants with advanced solid tumors; study terminated with results posted.